The Plant Proteinase Inhibitor CrataBL Plays a Role in Controlling Asthma Response in Mice

Background. CrataBL is a protein isolated from Crataeva tapia bark. It has been shown to exhibit several biological properties, including anti-inflammatory, analgesic, antitumor, and insecticidal activities. There are no studies evaluating the role of CrataBL in experimental asthma models. Aim. To evaluate the effects of CrataBL on lung mechanics, inflammation, remodeling, and oxidative stress activation of mice with allergic pulmonary inflammation. Materials and Methods. BALB/c mice (6-7 weeks old, 25-30g) were divided into four groups: nonsensitized and nontreated mice (C group, n=8); ovalbumin- (OVA-) sensitized and nontreated mice (OVA group, n=8); nonsensitized and CrataBL-treated mice (C+CR group, n=8); OVA-sensitized and CrataBL-treated mice (OVA+CR group, n=8). We evaluated hyperresponsiveness to methacholine, bronchoalveolar lavage fluid (BALF), pulmonary inflammation, extracellular matrix remodeling, and oxidative stress markers. Results. CrataBL treatment in OVA- sensitized mice (OVA+CR group) attenuated the following variables compared to OVA- sensitized mice without treatment (OVA group) (all p<0.05): (1) respiratory system resistance (Rrs) and elastance (Ers) after methacholine challenge; (2) total cells, macrophages, polymorphonuclear cells, and lymphocytes in BALF; (3) eosinophils and volume fraction of collagen and elastic fibers in the airway and alveolar wall according to histopathological and morphometry analysis; (4) IL-4-, IL-5-, IL-13-, IL-17-, IFN-gamma-, MMP-9-, TIMP-1-, TGF-beta-, iNOS-, and NF-kB-positive cells and volume of 8-iso-PGF2 in airway and alveolar septa according to immunohistochemistry; and (5) IL-4, IL-5, and IFN-according to an ELISA. Conclusion. CrataBL contributes to the control of hyperresponsiveness, pulmonary inflammation, extracellular matrix remodeling, and oxidative stress responses in an animal model of chronic allergic pulmonary inflammation.

URI

https://observatorio.fm.usp.br/handle/OPI/29364

Referências

Almeida PC, 2001, J BIOL CHEM, V276, P944, DOI 10.1074/jbc.M003820200
Almeida-Reis R, 2017, BIOMED RES INT, DOI 10.1155/2017/8287125
Ambrosi M, 2005, ORG BIOMOL CHEM, V3, P1593, DOI 10.1039/b414350g
Arantes-Costa FM, 2008, TOXICOL PATHOL, V36, P680, DOI 10.1177/0192623308317427
Araujo RMS, 2011, NAT PRODUCT BIOPROSP, V1, P97, DOI 10.1007/s13659-011-0014-8
Asaduzzaman M, 2018, ALLERGY, V73, P416, DOI 10.1111/all.13313
Aun MV, 2017, J ASTHMA ALLERGY, V10, P293, DOI 10.2147/JAA.S121092
Bergeron C, 2010, CAN RESPIR J, V17, pE85, DOI 10.1155/2010/318029
Bruggemann TR, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00718
Cockcroft DW, 2006, J ALLERGY CLIN IMMUN, V118, P551, DOI 10.1016/j.jaci.2006.07.012
Croisant S, 2014, ADV EXP MED BIOL, V795, P17, DOI 10.1007/978-1-4614-8603-9_2
de Araujo RMS, 2011, THROMB RES, V128, P395, DOI 10.1016/j.thromres.2011.06.005
de Boer JD, 2012, BLOOD, V119, P3236, DOI 10.1182/blood-2011-11-391532
DEARAUJO RMS, 2012, J PLANT SCI, V183, P20, DOI 10.1016/J.PLANTSCI.2011.10.018
Ferreira R. D. S., 2013, PLOS ONE, V8
Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974
GINA Global Initiative for Asthma, 2018, GLOB IN ASTHM GLOB S
Goleva E, 2007, J ALLERGY CLIN IMMUN, V120, P1065, DOI 10.1016/j.jaci.2007.07.042
Gozzo AJ, 2006, BIOL CHEM, V387, P1129, DOI 10.1515/BC.2006.139
GREEN AA, 1955, METHOD ENZYMOL, V1, P67, DOI 10.1016/0076-6879(55)01014-8
Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262
Israel E, 2017, NEW ENGL J MED, V377, P965, DOI 10.1056/NEJMra1608969
Kauffman H. F., 2003, CURRENT ALLERGY ASTH, V3, P430
Kruse R. L., 2017, ALLERGY EUROPEAN J A, V73, P313
Lakshmi R T S, 2011, Ann Burns Fire Disasters, V24, P24
Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008
Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V125, pS95, DOI 10.1016/j.jaci.2009.10.047
Lin Chih-Che, 2014, MEDIAT INFLAMM, V2014
Lin SC, 2017, ARCH MED SCI, V13, P670, DOI 10.5114/aoms.2016.60371
LOWRY OH, 1951, J BIOL CHEM, V193, P265
Martins-Olivera B. T., 2016, MEDIAT INFLAMM, V2016
Menzella F., 2015, MULTIDISCIPLINARY RE, V10
Neuhof C, 2003, BIOL CHEM, V384, P939, DOI 10.1515/BC.2003.105
Nunes NNS, 2015, J AGR FOOD CHEM, V63, P10431, DOI 10.1021/acs.jafc.5b03634
Oliva MLV, 2009, AN ACAD BRAS CIENC, V81, P615, DOI 10.1590/S0001-37652009000300023
Oliveira C, 2010, BRIT J PHARMACOL, V161, P899, DOI 10.1111/j.1476-5381.2010.00924.x
Pantano C, 2008, AM J RESP CRIT CARE, V177, P959, DOI 10.1164/rccm.200707-10960C
Prado Carla M, 2011, ISRN Allergy, V2011, P832560, DOI 10.5402/2011/832560
Prado CM, 2011, EXP LUNG RES, V37, P259, DOI 10.3109/01902148.2010.538289
Rice JB, 2017, CLIN THER, V39, P2216, DOI 10.1016/j.clinthera.2017.09.011
Rico-Rosillo Guadalupe, 2011, Rev Alerg Mex, V58, P107
RighettI RF, 2014, RESP PHYSIOL NEUROBI, V192, P134, DOI 10.1016/j.resp.2013.12.012
Salu BR, 2014, BIOL CHEM, V395, P1027, DOI 10.1515/hsz-2014-0127
Saraiva-Romanholo BM, 2003, CHEST, V124, P1060, DOI 10.1378/chest.124.3.1060
Schutz VCR, 2009, RESP PHYSIOL NEUROBI, V165, P13, DOI 10.1016/j.resp.2008.09.007
Shigetomi H, 2010, INFLAMM RES, V59, P679, DOI 10.1007/s00011-010-0205-5
Tang LF, 2006, FETAL PEDIATR PATHOL, V25, P1, DOI 10.1080/15227950600701396
Theodoro-Junior O. A., 2017, INT J MOL SCI, V18
Toledo AC, 2011, RESP PHYSIOL NEUROBI, V177, P155, DOI 10.1016/j.resp.2011.03.016
Trevor JL, 2014, ALLERGY, V69, P817, DOI 10.1111/all.12412
U.S. National Institute of Health, 2002, I AN CAR US COMM GUI
Oliva MLV, 2011, CURR PROTEIN PEPT SC, V12, P348
Voynow JA, 2011, BBA-GEN SUBJECTS, V1810, P1091, DOI 10.1016/j.bbagen.2011.04.016
WEIBEL ER, 1963, LAB INVEST, V12, P131
Zhang FM, 2013, BIOCHEMISTRY-US, V52, P2148, DOI 10.1021/bi400077b

Coleções

Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/20
Artigos e Materiais de Revistas Científicas - ODS/03

Página do item completo